HEMOGLOBIN S

Clinical trials for HEMOGLOBIN S explained in plain language.

Never miss a new study

Get alerted when new HEMOGLOBIN S trials appear

Sign up with your email to follow new studies for HEMOGLOBIN S, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human test of new sickle cell pill begins

Disease control Recruiting now

This is an early safety study to see if a pill called fostamatinib is safe and tolerable for adults with stable sickle cell disease. Up to 25 participants will take the drug at home for 6 weeks, with visits every 2 weeks to check for side effects. The main goal is to find a safe …

Matched conditions: HEMOGLOBIN S

Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

HEMOGLOBIN S

Get alerted when new HEMOGLOBIN S trials appear

First human test of new sickle cell pill begins